Buy & Sell Summit Therapeutics Inc (SMMT) – Summit Therapeutics Inc Price Today
Aura AI Summary
Key Stats
- $18.93BMarket Cap
- HealthSector
- -20.26%3M Drawdown
- $18.24BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 0 daysTypical Hold Time
Summit Therapeutics Inc (SMMT) is currently valued at a market capitalization of $18.93B, with an enterprise value of $18.24B. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $13.85 and a high of $36.7, highlighting its annual price range. Over the past three months, Summit Therapeutics Inc has recorded a drawdown of -20.26%, reflecting recent price volatility. On average, investors hold Summit Therapeutics Inc for approximately 0 days, indicating typical investor behavior on the platform.
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
